Pulmonology Archives - Page 48 of 60

News
Azithromycin for COPD exacerbations may reduce treatment failure
September 17, 2018
PARIS – Started when patients with COPD are hospitalized for an exacerbation, a 90-day course of azithromycin improved multiple outcome measures in a placebo-controlled trial.
News
Review protocols, follow reprocessing guidelines to cut device-related HAIs
September 11, 2018
Environmental pathogens associated with medical devices or device reprocessing are often the cause of HAI-related investigations.
News
Single-dose influenza drug baloxavir similar to oseltamivir in efficacy
September 5, 2018
A new single-dose influenza antiviral drug has similar time to symptom alleviation compared with oseltamivir, but greater reductions in viral load.
News
Service, please: Hospital setting matters for pneumonia
September 5, 2018
Frequency of bacteriology/microbiology testing, CT scans differs between inpatient and ED settings.
News
Variation in bacterial drug susceptibility tied to TB relapse risk
August 29, 2018
Higher pretreatment drug concentrations close to susceptibility breakpoint predicted relapse in patients with TB.
News
Rivaroxaban superior to aspirin for extended VTE treatment
August 29, 2018
Researchers said there is no longer a place for aspirin in extended VTE treatment.
News
Declining lung function linked to heart failure, stroke
August 28, 2018
Cardiologists and pulmonologists should collaborate to better identify the relationship between lung function decline and early CV disease detection.
News
Some PE patients don’t require hospitalization
August 21, 2018
A risk assessment of patients with pulmonary embolism could prevent some hospitalizations.
News
Next-gen sputum PCR panel boosts CAP diagnostics
August 10, 2018
NEW ORLEANS – The BioFire film array panel is now before the FDA.
News
PE is rare in patients presenting to the ED with syncope
August 3, 2018
Clinical question: What is the prevalence of pulmonary embolism (PE) in patients presenting to the ED with syncope?